Tarja Heiskanen

1.7k total citations
28 papers, 1.3k citations indexed

About

Tarja Heiskanen is a scholar working on Anesthesiology and Pain Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tarja Heiskanen has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Anesthesiology and Pain Medicine, 9 papers in Physiology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Tarja Heiskanen's work include Pain Management and Opioid Use (17 papers), Pain Mechanisms and Treatments (8 papers) and Musculoskeletal pain and rehabilitation (6 papers). Tarja Heiskanen is often cited by papers focused on Pain Management and Opioid Use (17 papers), Pain Mechanisms and Treatments (8 papers) and Musculoskeletal pain and rehabilitation (6 papers). Tarja Heiskanen collaborates with scholars based in Finland, Sweden and Denmark. Tarja Heiskanen's co-authors include Eija Kalso, Klaus T. Olkkola, Anja Siitonen, Risto P. Roine, Katri Hamunen, Vesa Kontinen, Per H. Rosenberg, Anneli Vainio, Harri Sintonen and Sigurður Árnason and has published in prestigious journals such as Scientific Reports, Pain and Journal of Clinical Microbiology.

In The Last Decade

Tarja Heiskanen

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarja Heiskanen Finland 19 750 455 334 261 243 28 1.3k
Phil Wiffen United Kingdom 8 203 0.3× 129 0.3× 511 1.5× 105 0.4× 121 0.5× 39 1.4k
Daniel P. Wermeling United States 22 340 0.5× 287 0.6× 212 0.6× 403 1.5× 160 0.7× 56 1.7k
Gary Ruoff United States 21 193 0.3× 68 0.1× 325 1.0× 157 0.6× 348 1.4× 77 1.6k
Che Suraya Zin Malaysia 14 196 0.3× 97 0.2× 160 0.5× 216 0.8× 57 0.2× 34 753
Jeffrey Gudin United States 18 396 0.5× 181 0.4× 222 0.7× 535 2.0× 156 0.6× 62 1.2k
Pirkko Paakkari Finland 12 142 0.2× 70 0.2× 99 0.3× 150 0.6× 27 0.1× 26 684
Jeffrey Fudin United States 17 381 0.5× 159 0.3× 193 0.6× 369 1.4× 167 0.7× 50 900
Howard A. Heit United States 14 598 0.8× 190 0.4× 202 0.6× 687 2.6× 172 0.7× 27 1.1k
E. J. Cone United States 20 294 0.4× 282 0.6× 242 0.7× 911 3.5× 58 0.2× 24 2.1k
M. Mandelli Italy 14 98 0.1× 202 0.4× 31 0.1× 61 0.2× 33 0.1× 27 944

Countries citing papers authored by Tarja Heiskanen

Since Specialization
Citations

This map shows the geographic impact of Tarja Heiskanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarja Heiskanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarja Heiskanen more than expected).

Fields of papers citing papers by Tarja Heiskanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarja Heiskanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarja Heiskanen. The network helps show where Tarja Heiskanen may publish in the future.

Co-authorship network of co-authors of Tarja Heiskanen

This figure shows the co-authorship network connecting the top 25 collaborators of Tarja Heiskanen. A scholar is included among the top collaborators of Tarja Heiskanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarja Heiskanen. Tarja Heiskanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heiskanen, Tarja, et al.. (2022). Opioid trends in Finland: a register-based nationwide follow-up study. Scientific Reports. 12(1). 7261–7261. 15 indexed citations
2.
3.
Hamunen, Katri, et al.. (2017). Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients. Scandinavian Journal of Pain. 16(1). 140–145. 15 indexed citations
4.
Tiippana, Elina, et al.. (2016). New approach for treatment of prolonged postoperative pain: APS Out-Patient Clinic. Scandinavian Journal of Pain. 12(1). 19–24. 55 indexed citations
5.
Heiskanen, Tarja, Kaarina Langel, Teemu Gunnar, Pirjo Lillsunde, & Eija Kalso. (2014). Opioid Concentrations in Oral Fluid and Plasma in Cancer Patients With Pain. Journal of Pain and Symptom Management. 50(4). 524–532. 29 indexed citations
6.
Simojoki, Kaarlo, et al.. (2013). Opioidit pitkäaikaisen kivun hoidossa. 68. 3329–3335. 1 indexed citations
7.
Heiskanen, Tarja, Risto P. Roine, & Eija Kalso. (2012). Multidisciplinary pain treatment – Which patients do benefit?. Scandinavian Journal of Pain. 3(4). 201–207. 26 indexed citations
8.
Heiskanen, Tarja & Eija Kalso. (2012). Non-Analgesic Effects of Opioids: Interactions Between Opioids and Other Drugs. Current Pharmaceutical Design. 18(37). 6079–6089. 10 indexed citations
9.
Kaasa, Stein, Giovanni Apolone, Pål Klepstad, et al.. (2011). Expert conference on cancer pain assessment and classification—the need for international consensus: working proposals on international standards. BMJ Supportive & Palliative Care. 1(3). 281–287. 48 indexed citations
10.
Lemberg, Kim K., Tarja Heiskanen, Mikko Neuvonen, et al.. (2009). Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients. Scandinavian Journal of Pain. 1(1). 24–33. 22 indexed citations
11.
Heiskanen, Tarja, et al.. (2009). Transdermal fentanyl in cachectic cancer patients. Pain. 144(1). 218–222. 67 indexed citations
12.
Kress, Hans G., Klaus Hoerauf, Thomas Nolte, et al.. (2008). A Randomized, Open, Parallel Group, Multicenter Trial to Investigate Analgesic Efficacy and Safety of a New Transdermal Fentanyl Patch Compared to Standard Opioid Treatment in Cancer Pain. Journal of Pain and Symptom Management. 36(3). 268–279. 38 indexed citations
13.
Svendsen, Kristina B., Steen Andersen, Sigurður Árnason, et al.. (2004). Breakthrough pain in malignant and non‐malignant diseases: a review of prevalence, characteristics and mechanisms. European Journal of Pain. 9(2). 195–206. 143 indexed citations
14.
Heiskanen, Tarja, et al.. (2002). Analgesic effects of dextromethorphan and morphine in patients with chronic pain. Pain. 96(3). 261–267. 36 indexed citations
15.
Eklund, Marjut, et al.. (2001). EPEC, EAEC and STEC in stool specimens: prevalence and molecular epidemiology of isolates. Diagnostic Microbiology and Infectious Disease. 40(4). 151–156. 60 indexed citations
16.
Heiskanen, Tarja, et al.. (1998). Shiga Toxin-Producing Escherichia coli in Finland from 1990 through 1997: Prevalence and Characteristics of Isolates. Journal of Clinical Microbiology. 36(12). 3641–3646. 63 indexed citations
17.
Heiskanen, Tarja, Klaus T. Olkkola, & Eija Kalso. (1998). Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone*. Clinical Pharmacology & Therapeutics. 64(6). 603–611. 182 indexed citations
18.
Heiskanen, Tarja & Eija Kalso. (1997). Controlled-release oxycodone and morphine in cancer related pain. Pain. 73(1). 37–45. 182 indexed citations
19.
Kalso, Eija, et al.. (1996). Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study. Pain. 67(2). 443–449. 73 indexed citations
20.
Ikäheimo, Risto, et al.. (1994). Community-acquired Pyelonephritis in Adults: Characteristics of E. coli Isolates in Bacteremic and Non-bacteremic Patients. Scandinavian Journal of Infectious Diseases. 26(3). 289–296. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phil Wiffen Breakdown of academic impact, for papers by Daniel P. Wermeling Breakdown of academic impact, for papers by Gary Ruoff Breakdown of academic impact, for papers by Che Suraya Zin Breakdown of academic impact, for papers by Jeffrey Gudin Breakdown of academic impact, for papers by Pirkko Paakkari Breakdown of academic impact, for papers by Jeffrey Fudin Breakdown of academic impact, for papers by Howard A. Heit Breakdown of academic impact, for papers by E. J. Cone Breakdown of academic impact, for papers by M. Mandelli
Rankless by CCL
2026